Search results for "Heart Failure"


 
Results 1 - 10 of about 487 for "Heart Failure".
Sort by: Relevance | Newest | Oldest

Wearable sensor reduces heart failure rehospitalization, industry study finds

A temporary wearable device plus additional remote monitoring reduced heart failure readmissions by 38% among high-risk patients, a manufacturer's trial found.
https://immattersacp.org/weekly/archives/2024/10/15/4.htm
15 Oct 2024

Obesity hypoventilation syndrome often overlooked

The condition is likely to show up more often in primary care as rates of obesity in the United States climb.
https://immattersacp.org/archives/2025/01/obesity-hypoventilation-syndrome-often-overlooked.htm
1 Jan 2025

MKSAP Quiz: Evaluation for heart failure

A 78-year-old woman is evaluated for a 3-month history of heart failure with reduced ejection fraction (ejection fraction, 20%). She has stable dyspnea when walking up stairs but has no other symptoms. Following a physical exam, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2024/10/22/3.htm
22 Oct 2024

MRAs appear effective for heart failure across the range of ejection fractions

Steroidal mineralocorticoid receptor antagonists (MRAs) (e.g., spironolactone and eplerenone) reduced risk for cardiovascular death or heart failure hospitalization in patients with heart failure and reduced ejection fraction (EF), while nonsteroidal MRAs (e.g., finerenone) seemed beneficial in those with mildly reduced or preserved EF, an individual-patient level meta-analysis found.
https://immattersacp.org/weekly/archives/2024/09/10/4.htm
10 Sep 2024

When the doctor will (not) see you now

For many Americans, it is difficult to see a physician for an acute symptom, and almost impossible to get a primary care appointment for routine care in a reasonable amount of time.
https://immattersacp.org/archives/2024/11/when-the-doctor-will-not-see-you-now.htm
1 Nov 2024

Examining cost effects of ‘skinny-label’ generics

A federal ruling over a patent dispute could lead to long-term effects on health care spending in the United States, a recent study indicated.
https://immattersacp.org/archives/2024/11/examining-cost-effects-of-skinny-label-generics.htm
1 Nov 2024

Diagnose, address cognitive impairment in heart failure patients, society says

A new scientific statement from the Heart Failure Society of America advises clinicians to be alert to clues such as difficulty with money or running out of medicine, among other recommendations.
https://immattersacp.org/weekly/archives/2024/03/19/4.htm
19 Mar 2024

Beta-blockers associated with worse outcomes in new PAH

Death or hospitalization due to right-heart failure or syncope was more likely in patients who received beta-blockers after a new pulmonary arterial hypertension (PAH) diagnosis, especially if they had no cardiovascular comorbidities, a retrospective Polish study found.
https://immattersacp.org/weekly/archives/2024/11/19/2.htm
19 Nov 2024

Lifestyle, treatment changes for afib

A new atrial fibrillation guideline focuses on early rhythm control and lifestyle changes such as physical activity and weight loss to slow or disrupt the course of the disease.
https://immattersacp.org/archives/2024/09/lifestyle-treatment-changes-for-afib.htm
1 Sep 2024

Intensive BP control improved outcomes in patients with type 2 diabetes, trial finds

A composite of nonfatal stroke, nonfatal myocardial infarction, treatment or hospitalization for heart failure, or death from cardiovascular causes was significantly lower among patients treated to a blood pressure (BP) target of less than 120 mm Hg versus one below 140 mm Hg.
https://immattersacp.org/weekly/archives/2024/11/26/4.htm
26 Nov 2024

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next